Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -98.40% | -97.72% | -14.61% | -10.37% | 5.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -98.40% | -97.72% | -14.61% | -10.37% | 5.69% |
| Cost of Revenue | -86.16% | -86.61% | -31.88% | -18.99% | -18.75% |
| Gross Profit | -101.15% | -100.28% | 61.92% | -7.62% | 13.34% |
| SG&A Expenses | -93.51% | -94.41% | -44.49% | -37.63% | 16.48% |
| Depreciation & Amortization | -97.35% | -94.85% | -45.31% | -23.75% | 50.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -92.61% | -93.23% | -40.48% | -32.30% | 10.63% |
| Operating Income | 68.72% | 72.99% | 47.15% | 363.18% | -37.09% |
| Income Before Tax | 77.92% | 37.88% | 36.63% | 62.56% | 13.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 77.92% | 39.66% | 36.63% | 22.13% | 13.04% |
| Earnings from Discontinued Operations | -- | -- | -1,628.19% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.92% | 54.85% | -47.92% | 678.05% | 13.04% |
| EBIT | 68.72% | 72.99% | 47.15% | 363.18% | -37.09% |
| EBITDA | 62.19% | 70.50% | 27.19% | 212.22% | -29.82% |
| EPS Basic | 78.15% | 53.80% | -43.10% | 671.94% | 14.69% |
| Normalized Basic EPS | 77.66% | 36.26% | 39.47% | 218.33% | -23.68% |
| EPS Diluted | 78.15% | 46.86% | -35.21% | 666.84% | 14.69% |
| Normalized Diluted EPS | 77.91% | 36.26% | 39.47% | 269.23% | -19.44% |
| Average Basic Shares Outstanding | 0.00% | -2.65% | 2.79% | 1.83% | 1.88% |
| Average Diluted Shares Outstanding | 0.00% | -2.65% | 2.79% | 2.22% | 7.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |